ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated. If you have any questions, please contact Marianne Reed at mreed@ku.edu .

Show simple item record

dc.contributor.authorAlrefai, Mohammad T.
dc.contributor.authorMurali, Divya
dc.contributor.authorPaul, Arghya
dc.contributor.authorRidwan, Khalid M.
dc.contributor.authorConnell, John M.
dc.contributor.authorShum-Tim, Dominique
dc.date.accessioned2016-12-08T19:39:04Z
dc.date.available2016-12-08T19:39:04Z
dc.date.issued2015-05-14
dc.identifier.citationShum-Tim, D., Ridwan, K., Alrefai, M., Connell, J., Paul, A., & Murali, D. (2015). Cardiac tissue engineering and regeneration using cell-based therapy. SCCAA, 81. doi:10.2147/sccaa.s54204en_US
dc.identifier.urihttp://hdl.handle.net/1808/22177
dc.description.abstractStem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. With these technologies, advancements are being made into therapies for acute ischemic myocardial injury and chronic, otherwise nonreversible, myocardial failure. The current clinical management of cardiac ischemia deals with reestablishing perfusion to the heart but not dealing with the irreversible damage caused by the occlusion or stenosis of the supplying vessels. The applications of these new technologies are not yet fully established as part of the management of cardiac diseases but will become so in the near future. The discussion presented here reviews some of the pioneering works at this new frontier. Key results of allogeneic and autologous stem cell trials are presented, including the use of embryonic, bone marrow-derived, adipose-derived, and resident cardiac stem cells.en_US
dc.publisherDove Medical Pressen_US
dc.rights© 2015 Alrefai et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/
dc.subjectstem cellsen_US
dc.subjectcardiomyocytesen_US
dc.subjectcardiac surgeryen_US
dc.subjectheart failureen_US
dc.subjectmyocardial ischemiaen_US
dc.subjecthearten_US
dc.subjectscaffoldsen_US
dc.subjectorganoidsen_US
dc.subjectcell sheet and tissue engineeringen_US
dc.titleCardiac tissue engineering and regeneration using cell-cased therapyen_US
dc.typeArticleen_US
kusw.kuauthorPaul, Arghya
kusw.kudepartmentChemical and Petroleum Engineeringen_US
dc.identifier.doi10.2147/SCCAA.S54204en_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2015 Alrefai et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Except where otherwise noted, this item's license is described as: © 2015 Alrefai et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php